Bradley Saenger - Dec 31, 2021 Form 5 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Chief Financial Officer
Signature
/s/ Bradley Saenger
Stock symbol
TNXP
Transactions as of
Dec 31, 2021
Transactions value $
$10,584
Form type
5
Date filed
2/11/2022, 04:18 PM
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Award $10.6K +18.2K +1306.23% $0.58 19.6K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan.